Clinical Trial

China Inherited Ventricular Arrhythmias Registry

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2019 (before its estimated October 24, 2022 completion). Its status may not reflect the trial's current state.
Summary
This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-03-17.
Trial Details
NCT Number NCT03880708
Lead Sponsor China National Center for Cardiovascular Diseases
Collaborators: Renmin Hospital of Wuhan University, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital of Nanchang University, Sir Run Run Shaw Hospital, West China Hospital, Beijing Anzhen Hospital, General Hospital of Shenyang Military Region, Xuzhou Central Hospital, First Affiliated Hospital, Sun Yat-Sen University
Conditions Ventricular Arrythmia
Enrollment 500 participants
Start Date 2017-10-24
Primary Completion 2022-10-24 (estimated)
Study Completion 2027-10-24 (estimated)
Updated on ClinicalTrials.gov 2019-03-26